Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.

Halene TB, Ehrlichman RS, Liang Y, Christian EP, Jonak GJ, Gur TL, Blendy JA, Dow HC, Brodkin ES, Schneider F, Gur RC, Siegel SJ.

Genes Brain Behav. 2009 Oct;8(7):661-75. doi: 10.1111/j.1601-183X.2009.00504.x. Epub 2009 May 8.

2.

Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice.

Bodarky CL, Halene TB, Ehrlichman RS, Banerjee A, Ray R, Hahn CG, Jonak G, Siegel SJ.

J Pharmacol Exp Ther. 2009 Oct;331(1):308-18. doi: 10.1124/jpet.109.150938. Epub 2009 Jul 14.

3.

Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?

Gandal MJ, Anderson RL, Billingslea EN, Carlson GC, Roberts TP, Siegel SJ.

Genes Brain Behav. 2012 Aug;11(6):740-50. doi: 10.1111/j.1601-183X.2012.00816.x.

4.

Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function.

Duncan GE, Inada K, Koller BH, Moy SS.

Brain Res. 2010 Jan 11;1307:166-76. doi: 10.1016/j.brainres.2009.10.023. Epub 2009 Oct 22.

5.

Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.

Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, Snouwaert JN, Koller BH.

Behav Brain Res. 2004 Aug 31;153(2):507-19.

PMID:
15265649
6.

NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia.

Ramsey AJ.

Prog Brain Res. 2009;179:51-8. doi: 10.1016/S0079-6123(09)17906-2. Epub 2009 Nov 20. Review.

PMID:
20302817
7.

NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity.

Li B, Devidze N, Barengolts D, Prostak N, Sphicas E, Apicella AJ, Malinow R, Emamian ES.

J Neurosci. 2009 Sep 23;29(38):11965-72. doi: 10.1523/JNEUROSCI.2109-09.2009.

8.

Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function.

Duncan G, Miyamoto S, Gu H, Lieberman J, Koller B, Snouwaert J.

Brain Res. 2002 Oct 4;951(2):166-76.

PMID:
12270494
9.

Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.

Moy SS, Perez A, Koller BH, Duncan GE.

Brain Res. 2006 May 17;1089(1):186-94. Epub 2006 Apr 25.

PMID:
16638606
10.

Mutation analysis of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia.

Sakurai K, Toru M, Yamakawa-Kobayashi K, Arinami T.

Neurosci Lett. 2000 Dec 22;296(2-3):168-70.

PMID:
11109007
11.

Seizure responses and induction of Fos by the NMDA agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunction.

Duncan GE, Inada K, Farrington JS, Koller BH.

Brain Res. 2008 Jul 24;1221:41-8. doi: 10.1016/j.brainres.2008.05.001. Epub 2008 May 8.

12.

Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice.

Labrie V, Wang W, Barger SW, Baker GB, Roder JC.

Genes Brain Behav. 2010 Feb;9(1):11-25. doi: 10.1111/j.1601-183X.2009.00529.x. Epub 2009 Aug 5.

13.

Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits.

Billingslea EN, Tatard-Leitman VM, Anguiano J, Jutzeler CR, Suh J, Saunders JA, Morita S, Featherstone RE, Ortinski PI, Gandal MJ, Lin R, Liang Y, Gur RE, Carlson GC, Hahn CG, Siegel SJ.

Neuropsychopharmacology. 2014 Jun;39(7):1603-13. doi: 10.1038/npp.2014.7. Epub 2014 Feb 14.

14.

GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.

Gandal MJ, Sisti J, Klook K, Ortinski PI, Leitman V, Liang Y, Thieu T, Anderson R, Pierce RC, Jonak G, Gur RE, Carlson G, Siegel SJ.

Transl Psychiatry. 2012 Jul 17;2:e142. doi: 10.1038/tp.2012.69.

15.

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.

Weickert CS, Fung SJ, Catts VS, Schofield PR, Allen KM, Moore LT, Newell KA, Pellen D, Huang XF, Catts SV, Weickert TW.

Mol Psychiatry. 2013 Nov;18(11):1185-92. doi: 10.1038/mp.2012.137. Epub 2012 Oct 16.

16.

Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.

Labrie V, Clapcote SJ, Roder JC.

Pharmacol Biochem Behav. 2009 Feb;91(4):610-20. doi: 10.1016/j.pbb.2008.09.016. Epub 2008 Oct 7.

PMID:
18940194
17.

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes.

Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, Li Y, Quinlan EM, Nakazawa K.

Nat Neurosci. 2010 Jan;13(1):76-83. doi: 10.1038/nn.2447. Epub 2009 Nov 15.

18.

Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia.

Guo X, Hamilton PJ, Reish NJ, Sweatt JD, Miller CA, Rumbaugh G.

Neuropsychopharmacology. 2009 Jun;34(7):1659-72. doi: 10.1038/npp.2008.223. Epub 2009 Jan 14.

19.

Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress.

Duncan GE, Inada K, Farrington JS, Koller BH, Moy SS.

Brain Res. 2009 Apr 10;1265:186-95. doi: 10.1016/j.brainres.2009.02.002. Epub 2009 Feb 13.

20.

Preweaning sensorimotor deficits and adolescent hypersociability in Grin1 knockdown mice.

Moy SS, Nikolova VD, Riddick NV, Baker LK, Koller BH.

Dev Neurosci. 2012;34(2-3):159-73. Epub 2012 May 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk